Will Ashworth

Will Ashworth

Expertise: Public and private companies, Portfolio construction

About Will:
Will Ashworth has written about investments full-time since 2008. He loves investing and is passionate about helping others put their money to work. He particularly enjoys creating model portfolios that stand the test of time.

Publications where he’s appeared include InvestorPlace, The Motley Fool Canada, Investopedia, Kiplinger, and several others in both the U.S. and Canada. He lives in Halifax, Nova Scotia.

You can follow Will on LinkedIn. 

Recent Articles

Is Chesapeake Energy the Next Kodak?

A segment of investors holds out hope that Chesapeake Energy stock will retain some value post-bankruptcy. Kodak suggests otherwise.

Why Are So Many SPACs Rushing to Go Public?

There’s no question in 2020 that SPAC IPOs have become the hottest thing since sliced bread. Not convinced? Just ask Bill Ackman about them. 

5 of the Best Equity Crowdfunding Platforms for Entrepreneurs

Entrepreneurs looking for financing for their next great project or idea ought to consider these five equity crowdfunding platforms.

Nvidia’s Next Stop Could Be $1,000 Per Share

In September 2018, I predicted Nvidia would hit $500 by the end of 2020. NVDA stock is just $53 from its target, so where does it go now?

The $6 Million Reason to Own Beyond Meat Stock

Beyond Meat reported Q2 2020 results on Aug. 4. A single move by management makes BYND stock a must-own proposition.   

AgEagle Aerial Systems Stock Is Flying off the Shelves 

AgEagle Aerial Systems is currently trading at 34 times assets. Does pivoting to package delivery help or hinder the valuation for UAVS stock?  

10 Small-Cap Stocks Ready to Become Large Caps

Technical analyst Jonathan Krinsky believes small-cap stocks could benefit from a rotation out of large-cap techs. Here are 10 to consider.

It’s a Mouthful but WiMi Hologram Cloud Stock Has Actual Merit

As speculative plays go, the WiMi Hologram Cloud stock seems like an investment that’s got the actual potential to deliver for shareholders. 

The Next Bull Run Will Be Harder For Sorrento Therapeutics

Jim Cramer recently called out the markets for not recognizing the potential of Sorrento Therapeutics and SRNE stock. Is he right? 

Why Doubts Remain About FuelCell Energy

In February, I recommended Bloom Energy over FuelCell Energy. Six months later, I still have my doubts about FCEL stock.